Health & Life Co., Ltd. (TPEX:1781)
Taiwan · Delayed Price · Currency is TWD 10.75
-0.10 (-0.92%)
Aug 26, 2026, 1:30 PM CST
Health & Life Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 400.09 | 398.05 | 706.39 | 601.17 | 797.54 | 811.88 | |
Revenue Growth | -30.90% | -43.65% | 17.50% | -24.62% | -1.77% | 4.87% |
Cost of Revenue | 345.21 | 327.93 | 558.65 | 508.07 | 699.82 | 766.12 |
Gross Profit | 54.88 | 70.12 | 147.74 | 93.11 | 97.73 | 45.76 |
Selling, General & Admin | 109.47 | 113.59 | 126.88 | 116.95 | 125.47 | 119.84 |
Research & Development | 20.44 | 19.94 | 18.35 | 16.16 | 17.34 | 22.81 |
Operating Expenses | 129.92 | 133.52 | 145.24 | 134.17 | 142.11 | 142.65 |
Operating Income | -75.04 | -63.41 | 2.5 | -41.06 | -44.39 | -96.89 |
Interest Expense | -5.79 | -5.98 | -3.38 | -5.27 | -3.14 | -3.08 |
Interest & Investment Income | 4.25 | 4.79 | 2.43 | 2.26 | 0.78 | 1.95 |
Currency Exchange Gain (Loss) | -7.78 | -7.78 | 19.15 | 3.91 | 22.79 | 24.28 |
Other Non Operating Income (Expenses) | 35.75 | 5.34 | 7.65 | 2.6 | 6.96 | -7.56 |
EBT Excluding Unusual Items | -48.61 | -67.03 | 28.35 | -37.57 | -17 | -81.3 |
Gain (Loss) on Sale of Investments | -0.32 | -0.32 | -0.02 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.06 | 0.01 | 1.45 | - |
Legal Settlements | - | - | - | - | - | -2 |
Other Unusual Items | - | - | 0.39 | - | 0.09 | - |
Pretax Income | -48.93 | -67.35 | 28.78 | -37.56 | -15.47 | -83.3 |
Income Tax Expense | 1.74 | -5.69 | 4.54 | -4.33 | 2.08 | -20.96 |
Net Income | -50.67 | -61.67 | 24.24 | -33.23 | -17.55 | -62.34 |
Net Income to Common | -50.67 | -61.67 | 24.24 | -33.23 | -17.55 | -62.34 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 47 | 47 | 47 | 47 | 47 | 47 |
Shares Outstanding (Diluted) | 47 | 47 | 50 | 47 | 47 | 47 |
Shares Change | -0.21% | -5.96% | 6.34% | - | - | -0.21% |
EPS (Basic) | -1.07 | -1.30 | 0.51 | -0.70 | -0.37 | -1.31 |
EPS (Diluted) | -1.07 | -1.30 | 0.48 | -0.70 | -0.37 | -1.31 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -24.37 | -3.74 | 30.65 | 76.94 | -85.44 | -143.53 |
Free Cash Flow Per Share | -0.52 | -0.08 | 0.61 | 1.62 | -1.80 | -3.03 |
Gross Margin | 13.72% | 17.61% | 20.91% | 15.49% | 12.25% | 5.64% |
Operating Margin | -18.75% | -15.93% | 0.35% | -6.83% | -5.56% | -11.93% |
Profit Margin | -12.66% | -15.49% | 3.43% | -5.53% | -2.20% | -7.68% |
Free Cash Flow Margin | -6.09% | -0.94% | 4.34% | 12.80% | -10.71% | -17.68% |
EBITDA | -65.27 | -52.94 | 14.5 | -29.21 | -34.51 | -89.91 |
EBITDA Margin | -16.31% | -13.30% | 2.05% | -4.86% | -4.33% | -11.07% |
D&A For EBITDA | 9.77 | 10.46 | 12.01 | 11.85 | 9.87 | 6.98 |
EBIT | -75.04 | -63.41 | 2.5 | -41.06 | -44.39 | -96.89 |
EBIT Margin | -18.75% | -15.93% | 0.35% | -6.83% | -5.56% | -11.93% |
Effective Tax Rate | - | - | 15.77% | - | - | - |